Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

The characteristics of HIV-positive patients with mild/asymptomatic and moderate/severe course of COVID-19 disease-A report from Central and Eastern Europe

JD. Kowalska, K. Kase, A. Vassilenko, A. Harxhi, B. Lakatos, GD. Lukić, A. Verhaz, N. Yancheva, F. Dumitrescu, D. Jilich, L. Machala, A. Skrzat-Klapaczyńska, R. Matulionyte

. 2021 ; 104 (-) : 293-296. [pub] 20201214

Jazyk angličtina Země Kanada

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc21019138

BACKGROUND: There is currently no evidence suggesting that COVID-19 takes a different course in HIV-positive patients on antiretroviral treatment compared to the general population. However, little is known about the relation between specific HIV-related factors and the severity of the COVID-19 disease. METHODS: We performed a retrospective analysis of cases collected through an on-line survey distributed by the Euroguidelines in Central and Eastern Europe Network Group. In statistical analyses characteristics of HIV-positive patients, asymptomatic/moderate and moderate/severe course were compared. RESULTS: In total 34 HIV-positive patients diagnosed with COVID-19 were reported by 12 countries (Estonia, Czech Republic, Lithuania, Albania, Belarus, Romania, Serbia, Bosnia and Herzegovina, Poland, Russia, Hungary, Bulgaria). Asymptomatic courses of COVID-19 were reported in four (12%) cases, 11 (32%) patients presented with mild disease not requiring hospitalization, moderate disease with respiratory and/or systemic symptoms was observed in 14 (41%) cases, and severe disease with respiratory failure was found in five (15%) patients. The HIV-related characteristics of patients with an asymptomatic/mild course of COVID-19 were comparable to those with a moderate/severe course of COVID-19, except for the use of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in cART regimen (0.0% vs. 31.6% respectively, p = 0.0239). CONCLUSIONS: In our analyses HIV viral suppression and immunological status were not associated with the course of COVID-19 disease. On the contrary the cART regimen could contribute to severity of SARS-CoV-2 infection. Large and prospective studies are necessary to further investigate this relationship.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21019138
003      
CZ-PrNML
005      
20210830100722.0
007      
ta
008      
210728s2021 xxc f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ijid.2020.12.026 $2 doi
035    __
$a (PubMed)33326871
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxc
100    1_
$a Kowalska, Justyna D $u Department of Adults' Infectious Diseases, Hospital for Infectious Diseases, Medical University of Warsaw, Poland. Electronic address: jdkowalska@gmail.com
245    14
$a The characteristics of HIV-positive patients with mild/asymptomatic and moderate/severe course of COVID-19 disease-A report from Central and Eastern Europe / $c JD. Kowalska, K. Kase, A. Vassilenko, A. Harxhi, B. Lakatos, GD. Lukić, A. Verhaz, N. Yancheva, F. Dumitrescu, D. Jilich, L. Machala, A. Skrzat-Klapaczyńska, R. Matulionyte
520    9_
$a BACKGROUND: There is currently no evidence suggesting that COVID-19 takes a different course in HIV-positive patients on antiretroviral treatment compared to the general population. However, little is known about the relation between specific HIV-related factors and the severity of the COVID-19 disease. METHODS: We performed a retrospective analysis of cases collected through an on-line survey distributed by the Euroguidelines in Central and Eastern Europe Network Group. In statistical analyses characteristics of HIV-positive patients, asymptomatic/moderate and moderate/severe course were compared. RESULTS: In total 34 HIV-positive patients diagnosed with COVID-19 were reported by 12 countries (Estonia, Czech Republic, Lithuania, Albania, Belarus, Romania, Serbia, Bosnia and Herzegovina, Poland, Russia, Hungary, Bulgaria). Asymptomatic courses of COVID-19 were reported in four (12%) cases, 11 (32%) patients presented with mild disease not requiring hospitalization, moderate disease with respiratory and/or systemic symptoms was observed in 14 (41%) cases, and severe disease with respiratory failure was found in five (15%) patients. The HIV-related characteristics of patients with an asymptomatic/mild course of COVID-19 were comparable to those with a moderate/severe course of COVID-19, except for the use of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in cART regimen (0.0% vs. 31.6% respectively, p = 0.0239). CONCLUSIONS: In our analyses HIV viral suppression and immunological status were not associated with the course of COVID-19 disease. On the contrary the cART regimen could contribute to severity of SARS-CoV-2 infection. Large and prospective studies are necessary to further investigate this relationship.
650    _2
$a dospělí $7 D000328
650    _2
$a antiretrovirové látky $x terapeutické užití $7 D044966
650    _2
$a COVID-19 $x komplikace $x virologie $7 D000086382
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a HIV infekce $x komplikace $x farmakoterapie $x virologie $7 D015658
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a inhibitory proteas $x terapeutické užití $7 D011480
650    _2
$a retrospektivní studie $7 D012189
650    12
$a SARS-CoV-2 $7 D000086402
650    _2
$a průzkumy a dotazníky $7 D011795
650    _2
$a farmakoterapie COVID-19 $7 D000093485
651    _2
$a východní Evropa $x epidemiologie $7 D005061
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kase, Kerstin $u West Tallinn Central Hospital, Estonia
700    1_
$a Vassilenko, Anna $u Belarusian State Medical University, Minsk, Belarus
700    1_
$a Harxhi, Arjan $u University Hospital Center of Tirana, Infectious Disease Service, Albania
700    1_
$a Lakatos, Botond $u National Institute of Hematology and Infectious Diseases, South-Pest Central Hospital, National Center of HIV, Hungary
700    1_
$a Lukić, Gordana Dragović $u Department of Pharmacology, Clinical Pharmacology and Toxicology, School of Medicine, University of Belgrade, Serbia
700    1_
$a Verhaz, Antonija $u Clinic for Infectious Diseases, University Clinical Centre of the Republic of Srpska, Banja Luka, The Republic of Srpska, Bosnia and Herzegovina; Department for Infectious Diseases, Faculty of Medicine, University of Banja Luka, Banja Luka, The Republic of Srpska, Bosnia and Herzegovina
700    1_
$a Yancheva, Nina $u Department for AIDS, Specialized Hospital for Active Treatment of Infectious and Parasitic Disease Sofia, Bulgaria
700    1_
$a Dumitrescu, Florentina $u University of Medicine and Pharmacy Craiova, Romania
700    1_
$a Jilich, David $u Department of Infectious Diseases, 1st Faculty of Medicine, Charles University in Prague and Na Bulovce Hospital, Czech Republic
700    1_
$a Machala, Ladislav $u Department of Infectious Diseases, 3rd Faculty of Medicine, Charles University in Prague and Na BuLovce Hospital, Czech Republic
700    1_
$a Skrzat-Klapaczyńska, Agata $u Department of Adults' Infectious Diseases, Hospital for Infectious Diseases, Medical University of Warsaw, Poland
700    1_
$a Matulionyte, Raimonda $u Department of Infectious Diseases and Dermatovenerology, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Lithuania
773    0_
$w MED00005677 $t International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases $x 1878-3511 $g Roč. 104, č. - (2021), s. 293-296
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33326871 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210830100722 $b ABA008
999    __
$a ok $b bmc $g 1690054 $s 1139584
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 104 $c - $d 293-296 $e 20201214 $i 1878-3511 $m International journal of infectious diseases $n Int J Infect Dis $x MED00005677
LZP    __
$a Pubmed-20210728

Najít záznam

Citační ukazatele

Možnosti archivace